Glass House Brands Inc.

US$2.08As of Sun 8 Nov 2026, 12:00 UTC
NYSE:GLASHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (19.03%)
Div yield —
ROE (28.58%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.93
PE TTM —
TSR TTM (70.31%)
Mkt cap US$196.0M
ROIC (18.02%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.11
1.67%
(26.47%)
Hold 9|11|3|3|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.04
0.04
0.04
17.37%
34.13%
24.80%
22.08%
Revenue$M
28.49
29.95
31.40
31.56
15.70%
17.30%
18.80%
15.65%
Peers (US$196.0M)
Cap (US$)
PE
194.9M
40.75x
Capital
TTM
5Y
10Y
Leveragex
1.339
0.214
0.194
EBIT/Intx
1.171
3.525
2.851
Own earn%
76.61
(137.62)
(152.71)
Sh yield%
45.81
39.83
38.84
Owners
Insiders/Inst%
8.11
37.60
Short interest%
3.82
SBC / revenue%
4.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
13–24
$1 testx
—
Incr. ROIC%
6